AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

SitaOD Met 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview SitaOD Met 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications, such as renal impairment and vision loss, and may lower the risk of cardiovascular events like heart attacks and strokes. Diabex Duo 50mg/500mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering health status, blood sugar readings, and concurrent medications. Taking it with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes control, as lifestyle significantly impacts management. Commonly reported side effects include nausea, diarrhea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical advice before use. Interactions with other medications are possible; complete disclosure of all medications is essential for safe use. Alcohol should be minimized due to its hypoglycemic effect. Kidney function and blood glucose levels are monitored regularly throughout treatment.

Primary Ingredients of SitaOD Met 50mg/500mg Tablet

There is no text provided to rewrite.

Uses of SitaOD Met 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of SitaOD Met 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet; do not fracture, chew, or pulverize it. SitaOD Met 50mg/500mg tablets should be administered with a meal.

Common Side effects of SitaOD Met 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use SitaOD Met 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The SitaOD Met 50mg/500mg tablet should be administered with a meal.

How SitaOD Met 50mg/500mg Tablet works:

SitaOD Met 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and SitaOD Met 50mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of SitaOD Met 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of SitaOD Met 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Caution is advised when prescribing SitaOD Met 50mg/500mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consultation with a physician is recommended. In patients exhibiting severe kidney disease, the use of SitaOD Met 50mg/500mg tablets is contraindicated. Routine monitoring of renal function is suggested during treatment.

LiverLiverUNSAFE

The use of SitaOD Met 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted unless otherwise directed by a physician. Consult your doctor before use.

What if you forget to take SitaOD Met 50mg/500mg Tablet :

Should you forget to take your SitaOD Met 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About SitaOD Met 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on SitaOD Met 50mg/500mg Tablet

SitaOD Met 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged use of SitaOD Met 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
SitaOD Met 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
SitaOD Met 50mg/500mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD Met 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
SitaOD Met 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
SitaOD Met 50mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
SitaOD Met 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD Met 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of SitaOD Met 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
SitaOD Met 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
SitaOD Met 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
SitaOD Met 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD Met 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the blood (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of SitaOD Met 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues like numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
SitaOD Met 50mg/500mg Tab...
91
MRP 106
14% off